Bristol Myers Squibb (BMY) Non-Current Assets (2009 - 2026)
Bristol Myers Squibb (BMY) reported Non-Current Assets of $59.06 billion for Q2 2026, down 3.9% from $61.45 billion a year earlier and down 0.4% from the prior quarter.
Bristol Myers Squibb (BMY) Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb posted Non-Current Assets of $60.65 billion, down 3.5% from FY2024.
- Non-Current Assets has declined for six consecutive years, with a five-year compound annual growth rate of -7.2% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $62.82 billion in FY2024 (-0.9%), $63.39 billion in FY2023 (-8.9%), $69.55 billion in FY2022 (-8.6%) and $76.05 billion in FY2021 (-13.9%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets since Q3 2019.
- Year over year, Non-Current Assets has now declined in each of the last seven quarters, with an average decline of 4.7% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q1 2024 (growth of 4.7%); the low point was Q1 2022 (a decline of 14.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $59.27 billion (Q1 2026), $60.65 billion (Q4 2025) and $61.26 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,159.35 Bn | 1,127.94 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 625.57 Bn | 544.10 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 510.56 Bn | 483.67 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.80 Bn | 321.17 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 296.71 Bn | 260.70 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 260.68 Bn | 234.36 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 235.19 Bn | 190.59 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.90 Bn | 169.09 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Bristol Myers Squibb | 124.13 Bn | 75.41 Bn | 9.25 Bn | 59.06 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.06 Bn |
| Mar 31, 2026 | 59.27 Bn |
| Dec 31, 2025 | 60.65 Bn |
| Sep 30, 2025 | 61.26 Bn |
| Jun 30, 2025 | 61.45 Bn |
| Mar 31, 2025 | 61.64 Bn |
| Dec 31, 2024 | 62.82 Bn |
| Sep 30, 2024 | 65.60 Bn |
| Jun 30, 2024 | 67.76 Bn |
| Mar 31, 2024 | 70.36 Bn |
| Dec 31, 2023 | 63.39 Bn |
| Sep 30, 2023 | 63.63 Bn |
| Jun 30, 2023 | 65.42 Bn |
| Mar 31, 2023 | 67.20 Bn |
| Dec 31, 2022 | 69.55 Bn |
| Sep 30, 2022 | 71.40 Bn |
| Jun 30, 2022 | 70.17 Bn |
| Mar 31, 2022 | 72.91 Bn |
| Dec 31, 2021 | 76.05 Bn |
| Sep 30, 2021 | 79.45 Bn |
Bristol Myers Squibb Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();